Ligand Pharmaceuticals
LGND
LGND
241 hedge funds and large institutions have $2.27B invested in Ligand Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 80 increasing their positions, 94 reducing their positions, and 40 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
241
Holders Change
-10
Holders Change %
-3.98%
% of All Funds
4.28%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
31
Increased
80
Reduced
94
Closed
40
Calls
$33.1M
Puts
$173M
Net Calls
-$140M
Net Calls Change
-$33.2M
Top Buyers
Top Sellers
1 |
Victory Capital Management
San Antonio,
Texas
|
-$25.1M |
2 |
BlackRock
New York
|
-$16.9M |
3 |
CC
Chicago Capital
Chicago,
Illinois
|
-$15.2M |
4 |
Citadel Advisors
Miami,
Florida
|
-$12.8M |
5 |
Two Sigma Advisers
New York
|
-$11.3M |